Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05797649 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comparing the Diagnostic Sensitivity and Specificity of Pleural Fluid N-Terminal Pro B-type Natriuretic Peptide (NT-proBNP) and Other Biochemical Gradient Criteria in Distinguishing Heart Failure and Non-heart Failure Related Pleural Effusions (CENTRE Study)

StatusCompleted
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial completed Final enrollment: 160 participants (planned 120) · Primary completion date changed from estimate of Nov 30, 2025 to Jun 30, 2025 · Eligibility criteria expanded, about 7 words · 2 more Show 5 more changesShow less
    • Final enrollment: 160 participants (planned 120)
    • Primary completion date changed from estimate of Nov 30, 2025 to Jun 30, 2025
    • Eligibility criteria expanded, about 7 words
    • Secondary endpoints: details revised at 1 of 3 entries
    • Site details revised
  2. Enrollment target: 300 to 120 Study title expanded, about 21 words · Study arms: 3 to 2v3 Show 2 more changesShow less
    • Study title expanded, about 21 words
    • Study arms: 3 to 2

    See this version in full on ClinicalTrials.gov ↗

  3. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1 · Start date changed from estimate of Dec 1, 2023 to Jul 1, 2023 · Collaborators expanded, about 3 wordsv2 Show 3 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Dec 1, 2023 to Jul 1, 2023
    • Collaborators expanded, about 3 words

    See this version in full on ClinicalTrials.gov ↗

  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To assess the discriminative properties of pleural fluid (PF) N-terminal-proB-type-natriuretic-peptide (NTproBNP) levels in identifying heart failure (HF)-associated pleural effusions (PE).
Trial Details
NCT Number NCT05797649
Lead Sponsor Chinese University of Hong Kong
Collaborators: Roche Diagnostics GmbH
Conditions Pleural Effusion, Heart Failure, Malignant Neoplasm, Fluid Overload, Hypoalbuminemia, Renal Failure, Cirrhosis, Infections
Enrollment 160 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov